Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Major Shareholding Notification 2015

Jul 9, 2015

3782_mrq_2015-07-09_4709bba8-2676-4eff-b5f4-635b24b03c47.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

VISTIN PHARMA ASA - SUBSTANTIAL SHAREHOLDING DISCLOSURE

VISTIN PHARMA ASA - SUBSTANTIAL SHAREHOLDING DISCLOSURE

Geveran Trading Co. Limited ("Geveran"), a company

indirectly controlled by trusts established by Mr.

John Fredriksen for the benefit of his immediate

family, has today acquired 881,422 shares in Vistin

Pharma ASA from an affiliated company, Famaday

Trading Inc. ("Famaday"). Following the acquisition,

Geveran holds 881,422 shares in Vistin Pharma,

equalling 5.17% of the shares and votes in the

company, and Famaday holds no shares in the company.

The foregoing calculations are made based on

17,054,935 outstanding shares in Vistin Pharma.

This announcement is made pursuant to section 4-3 of

the Norwegian Securities Trading Act.